(Q28189490)
Statements
Monitoring a clinical trial conducted under the Food and Drug Administration regulations allowing a waiver of prospective informed consent: the diaspirin cross-linked hemoglobin traumatic hemorrhagic shock efficacy trial (English)
0 references
October 2001
0 references
38
0 references
4
0 references
397-404
0 references